CS
IDXG

Credit Suisse’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Credit Suisse’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,300
Closed -$12K – 4115
2018
Q2 		$12K Hold
1,300
– – ﹤0.01% 3936
2018
Q1 		$11K Hold
1,300
– – ﹤0.01% 3934
2017
Q4 		$13K Hold
1,300
– – ﹤0.01% 3949
2017
Q3 		$20K Buy
+1,300
New +$15.3K ﹤0.01% 4157
2013
Q3 		– Sell
-203
Closed -$95K – 4438
2013
Q2 		$95K Buy
+203
New +$92.1K ﹤0.01% 4027

Other funds holding IDXG

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return